6 min read
LabWare Showcases the Future of Laboratory Informatics with Expanded SaaS LIMS
BOSTON, March 4, 2025 /PRNewswire/ -- Pittcon -- LabWare®, the global leader in Laboratory...
Centered around LabWare Mobile the portable disease lab kit includes tablet devices, a Wi-Fi hotspot to enable connectivity to the cloud, a battery pack, wireless label printer, and an optional portable analyzer for COVID-19 testing.
The kit connects to the LabWare LIMS software portal to capture patient demographic and clinical information, document field collection of respiratory swabs for testing, access the sample, and rapidly disseminate the data to public health agencies.
LabWare formed an exclusive partnership with a molecular diagnostic company that developed a respiratory panel assay capable of detecting COVID-19, Flu A, Flu B, and RSV simultaneously from a single sample. Patients with flu-like symptoms will know what they have and experience better clinical outcomes by having target-appropriate treatments.
Get more information on obtaining a Portable Disease Surveillance Lab for field testing.
→ 4 indicators that your lab is ready for a new LIMS
→ Breakdown of LIMS deployment options (SaaS v. PaaS v. Self-hosted)
→ 8 factors that determine the total cost of ownership of your LIMS
→ 5+ technical innovations built in LabWare 8
→ Visualizations of your instruments and systems interacting with LabWare 8
→ Overview of LabWare Mobile that brings portability to lab automation
